DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

CORONA Remedies Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 1 hr ago·16 Oct 2026, 7:30 am

CORONA Remedies

Corona Remedies Limited has announced its schedule for an upcoming meeting with analysts and institutional investors. This event is a standard corporate communication where the company management typically outlines its business strategy, financial outlook, and future growth plans to the investment community.

For investors, such meetings provide a valuable opportunity to gain clarity on the company's direction and assess management's confidence. It helps in understanding how the firm plans to navigate the competitive landscape and execute its vision, offering insights that go beyond the standard quarterly reports.

Investors should pay close attention to the management's commentary on operational performance and any guidance provided for future periods. This information is crucial for evaluating the company's potential and making informed decisions regarding their investment in the stock.